Ya-Li Cui
Overview
Explore the profile of Ya-Li Cui including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
61
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peng L, Gao Y, Cui Y, Xu H, Gao Z
Front Public Health
. 2023 Jan;
10:1073893.
PMID: 36684903
Congenital syphilis is a significant public health problem. Pregnant women infected with Treponema pallidum present with various clinical manifestations, mainly including skin or visceral manifestations. The extensive clinical manifestations of...
2.
Yang X, Liang J, Huang X, Wang X, Sun Y, Dong C, et al.
Biol Proced Online
. 2021 Jan;
23(1):2.
PMID: 33413084
Background: Angiotensin-converting enzyme (ACE) plays a major role in blood pressure regulation and cardiovascular homeostasis. The wide distribution and multifunctional properties of ACE suggest it's involvement in various pathophysiological conditions....
3.
Guan J, Zhao M, He C, Li X, Li Y, Sun J, et al.
Neurosci Bull
. 2018 Sep;
35(1):15-24.
PMID: 30173356
Fenofibrate, an agonist for peroxisome proliferator-activated receptor alpha (PPAR-α), lowers blood pressure, but whether this action is mediated via baroreflex afferents has not been elucidated. In this study, the distribution...
4.
Hao H, Wang Y, Wang X, Luan S, Cui J, Chen Y, et al.
Exp Ther Med
. 2017 Oct;
14(4):2795-2800.
PMID: 28966670
The objective of the present study was to observe the therapeutic effect of radiation delivered via a P source on Graves' ophthalmopathy. AP solution was injected into a 10-ml vacuum...
5.
Li X, Zhang C, Zhang Q, Zhu J, Liu Q, Chen M, et al.
Sci Rep
. 2017 Aug;
7(1):8346.
PMID: 28827701
Epidermal growth factor receptor (EGFR) mutations predict better outcomes with EGFR tyrosine kinase inhibitors in patients with non-small cell lung cancer (NSCLC). Most common activating mutations include in-frame deletion in...
6.
Zhang J, Cui Y, Jiang Y
Zhongguo Dang Dai Er Ke Za Zhi
. 2017 May;
19(5):583-589.
PMID: 28506354
Objective: To investigate the prokaryotic expression of proteins pneumococcal endopeptidase O (PepO) and pneumococcal surface adhesin A (PsaA) in Streptococcus pneumoniae and their immunoprotective effect as vaccine candidate proteins. Methods:...
7.
Zhang C, Yao Y, Zhu J, Zhang S, Zhang S, Wei H, et al.
Sci Rep
. 2016 Jun;
6:26533.
PMID: 27246657
Single-nucleotide polymorphisms (SNPs) represent the most widespread type of genetic variation (approximately 90%) in the human genome, and the demand to overcome such variation has received more attention now than...
8.
Cui Y, Wang X, Li X
Future Oncol
. 2015 Sep;
11(20):2841-9.
PMID: 26361064
Aim: To noninvasively observe dynamic changes in tumor hypoxia in mouse models of human non-small-cell lung cancer (NSCLC) using (18)F-fluoromisonidazole PET. Materials & Methods: Nude mice with NSCLC H460 and...
9.
Jin T, Ma L, Zhang J, Yuan D, Sun Q, Zong T, et al.
Gene
. 2013 May;
527(1):360-5.
PMID: 23644254
The cytochrome P450 2D6 enzyme (CYP2D6) metabolizes about 25% of prescribed drugs in the endoplasmic reticulum, and genetic polymorphisms in CYP2D6 can greatly affect its activity and lead to differences...
10.
Wang W, Zhang X, Wang Q, Wen D, Ouyang N, Cui Y, et al.
Zhonghua Xin Xue Guan Bing Za Zhi
. 2011 Dec;
39(8):695-9.
PMID: 22169413
Objective: To find the potential interference factors for the detection of NT-proBNP and BNP in patients with chronic heart failure. Methods: EP15-A2 issued by Clinical and Laboratory Standards Institute (CLSI)...